ROCHE HOLDING AG-BR (RHO.DE) Fundamental Analysis & Valuation

FRA:RHO • CH0012032113

Current stock price

351.8 EUR
0 (0%)
Last:

This RHO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. RHO.DE Profitability Analysis

1.1 Basic Checks

  • RHO had positive earnings in the past year.
  • In the past year RHO had a positive cash flow from operations.
  • Each year in the past 5 years RHO has been profitable.
  • Each year in the past 5 years RHO had a positive operating cash flow.
RHO.DE Yearly Net Income VS EBIT VS OCF VS FCFRHO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • RHO has a better Return On Assets (12.79%) than 82.35% of its industry peers.
  • With an excellent Return On Equity value of 38.10%, RHO belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 22.75%, RHO belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for RHO is significantly above the industry average of 14.61%.
  • The last Return On Invested Capital (22.75%) for RHO is above the 3 year average (22.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.79%
ROE 38.1%
ROIC 22.75%
ROA(3y)11.21%
ROA(5y)12.56%
ROE(3y)34.46%
ROE(5y)40.93%
ROIC(3y)22.13%
ROIC(5y)22.61%
RHO.DE Yearly ROA, ROE, ROICRHO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • The Profit Margin of RHO (20.94%) is better than 80.39% of its industry peers.
  • In the last couple of years the Profit Margin of RHO has declined.
  • With an excellent Operating Margin value of 34.41%, RHO belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
  • In the last couple of years the Operating Margin of RHO has remained more or less at the same level.
  • With a decent Gross Margin value of 73.62%, RHO is doing good in the industry, outperforming 64.71% of the companies in the same industry.
  • RHO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.41%
PM (TTM) 20.94%
GM 73.62%
OM growth 3Y3.59%
OM growth 5Y1.47%
PM growth 3Y2.18%
PM growth 5Y-3.1%
GM growth 3Y1.57%
GM growth 5Y0.32%
RHO.DE Yearly Profit, Operating, Gross MarginsRHO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. RHO.DE Health Analysis

2.1 Basic Checks

  • RHO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, RHO has about the same amount of shares outstanding.
  • The number of shares outstanding for RHO has been reduced compared to 5 years ago.
  • Compared to 1 year ago, RHO has an improved debt to assets ratio.
RHO.DE Yearly Shares OutstandingRHO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
RHO.DE Yearly Total Debt VS Total AssetsRHO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 4.45 indicates that RHO is not in any danger for bankruptcy at the moment.
  • RHO has a better Altman-Z score (4.45) than 64.71% of its industry peers.
  • The Debt to FCF ratio of RHO is 2.90, which is a good value as it means it would take RHO, 2.90 years of fcf income to pay off all of its debts.
  • RHO has a Debt to FCF ratio of 2.90. This is in the better half of the industry: RHO outperforms 70.59% of its industry peers.
  • A Debt/Equity ratio of 0.85 indicates that RHO is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.85, RHO is doing worse than 62.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 2.9
Altman-Z 4.45
ROIC/WACC4.39
WACC5.18%
RHO.DE Yearly LT Debt VS Equity VS FCFRHO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that RHO should not have too much problems paying its short term obligations.
  • RHO has a Current ratio (1.38) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.12 indicates that RHO should not have too much problems paying its short term obligations.
  • The Quick ratio of RHO (1.12) is better than 62.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.12
RHO.DE Yearly Current Assets VS Current LiabilitesRHO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

5

3. RHO.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.41% over the past year.
  • The Earnings Per Share has been growing slightly by 0.49% on average over the past years.
  • Looking at the last year, RHO shows a small growth in Revenue. The Revenue has grown by 1.69% in the last year.
  • The Revenue has been growing slightly by 1.07% on average over the past years.
EPS 1Y (TTM)4.41%
EPS 3Y-1.11%
EPS 5Y0.49%
EPS Q2Q%-0.47%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y-0.94%
Revenue growth 5Y1.07%
Sales Q2Q%-0.24%

3.2 Future

  • RHO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.38% yearly.
  • RHO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.63% yearly.
EPS Next Y5.01%
EPS Next 2Y6%
EPS Next 3Y6.61%
EPS Next 5Y8.38%
Revenue Next Year1.49%
Revenue Next 2Y2.67%
Revenue Next 3Y3.34%
Revenue Next 5Y4.63%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RHO.DE Yearly Revenue VS EstimatesRHO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
RHO.DE Yearly EPS VS EstimatesRHO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

5

4. RHO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.40, the valuation of RHO can be described as correct.
  • 62.75% of the companies in the same industry are more expensive than RHO, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of RHO to the average of the S&P500 Index (25.23), we can say RHO is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 15.62, the valuation of RHO can be described as correct.
  • 68.63% of the companies in the same industry are more expensive than RHO, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, RHO is valued a bit cheaper.
Industry RankSector Rank
PE 16.4
Fwd PE 15.62
RHO.DE Price Earnings VS Forward Price EarningsRHO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RHO indicates a somewhat cheap valuation: RHO is cheaper than 66.67% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of RHO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 23.89
EV/EBITDA 12.18
RHO.DE Per share dataRHO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RHO does not grow enough to justify the current Price/Earnings ratio.
  • RHO has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.28
PEG (5Y)33.76
EPS Next 2Y6%
EPS Next 3Y6.61%

6

5. RHO.DE Dividend Analysis

5.1 Amount

  • RHO has a Yearly Dividend Yield of 3.02%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.90, RHO pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.90, RHO pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.02%

5.2 History

  • The dividend of RHO has a limited annual growth rate of 2.49%.
Dividend Growth(5Y)2.49%
Div Incr Years0
Div Non Decr Years0
RHO.DE Yearly Dividends per shareRHO.DE Yearly Dividends per shareYearly Dividends per share 2019 2026 2 4 6 8

5.3 Sustainability

  • RHO pays out 65.10% of its income as dividend. This is not a sustainable payout ratio.
  • RHO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.1%
EPS Next 2Y6%
EPS Next 3Y6.61%
RHO.DE Yearly Income VS Free CF VS DividendRHO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
RHO.DE Dividend Payout.RHO.DE Dividend Payout, showing the Payout Ratio.RHO.DE Dividend Payout.PayoutRetained Earnings

RHO.DE Fundamentals: All Metrics, Ratios and Statistics

ROCHE HOLDING AG-BR

FRA:RHO (3/26/2026, 7:00:00 PM)

351.8

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners41.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap284.69B
Revenue(TTM)61.52B
Net Income(TTM)12.88B
Analysts70.34
Price Target400.71 (13.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.02%
Yearly Dividend11.59
Dividend Growth(5Y)2.49%
DP65.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.11%
PT rev (3m)14.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.29%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 16.4
Fwd PE 15.62
P/S 4.24
P/FCF 23.89
P/OCF 13.82
P/B 7.71
P/tB 37.28
EV/EBITDA 12.18
EPS(TTM)21.45
EY6.1%
EPS(NY)22.52
Fwd EY6.4%
FCF(TTM)14.72
FCFY4.19%
OCF(TTM)25.45
OCFY7.23%
SpS83.05
BVpS45.63
TBVpS9.44
PEG (NY)3.28
PEG (5Y)33.76
Graham Number148.41
Profitability
Industry RankSector Rank
ROA 12.79%
ROE 38.1%
ROCE 29.12%
ROIC 22.75%
ROICexc 22.75%
ROICexgc 35.66%
OM 34.41%
PM (TTM) 20.94%
GM 73.62%
FCFM 17.73%
ROA(3y)11.21%
ROA(5y)12.56%
ROE(3y)34.46%
ROE(5y)40.93%
ROIC(3y)22.13%
ROIC(5y)22.61%
ROICexc(3y)25.61%
ROICexc(5y)26.63%
ROICexgc(3y)43.58%
ROICexgc(5y)44.87%
ROCE(3y)28.23%
ROCE(5y)30.35%
ROICexgc growth 3Y-9.11%
ROICexgc growth 5Y-6.78%
ROICexc growth 3Y-8.02%
ROICexc growth 5Y-4.97%
OM growth 3Y3.59%
OM growth 5Y1.47%
PM growth 3Y2.18%
PM growth 5Y-3.1%
GM growth 3Y1.57%
GM growth 5Y0.32%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 2.9
Debt/EBITDA 1.21
Cap/Depr 293.21%
Cap/Sales 12.92%
Interest Coverage 17.8
Cash Conversion 78.95%
Profit Quality 84.67%
Current Ratio 1.38
Quick Ratio 1.12
Altman-Z 4.45
F-Score7
WACC5.18%
ROIC/WACC4.39
Cap/Depr(3y)191.25%
Cap/Depr(5y)158.91%
Cap/Sales(3y)9.7%
Cap/Sales(5y)8.71%
Profit Quality(3y)122.16%
Profit Quality(5y)118.22%
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3Y-1.11%
EPS 5Y0.49%
EPS Q2Q%-0.47%
EPS Next Y5.01%
EPS Next 2Y6%
EPS Next 3Y6.61%
EPS Next 5Y8.38%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y-0.94%
Revenue growth 5Y1.07%
Sales Q2Q%-0.24%
Revenue Next Year1.49%
Revenue Next 2Y2.67%
Revenue Next 3Y3.34%
Revenue Next 5Y4.63%
EBIT growth 1Y5.38%
EBIT growth 3Y2.62%
EBIT growth 5Y2.56%
EBIT Next Year21.68%
EBIT Next 3Y10.65%
EBIT Next 5Y12.14%
FCF growth 1Y-27.7%
FCF growth 3Y-6.29%
FCF growth 5Y-1.69%
OCF growth 1Y-6.18%
OCF growth 3Y1.93%
OCF growth 5Y0.31%

ROCHE HOLDING AG-BR / RHO.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-BR?

ChartMill assigns a fundamental rating of 6 / 10 to RHO.DE.


What is the valuation status of ROCHE HOLDING AG-BR (RHO.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to ROCHE HOLDING AG-BR (RHO.DE). This can be considered as Fairly Valued.


How profitable is ROCHE HOLDING AG-BR (RHO.DE) stock?

ROCHE HOLDING AG-BR (RHO.DE) has a profitability rating of 8 / 10.


What is the valuation of ROCHE HOLDING AG-BR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ROCHE HOLDING AG-BR (RHO.DE) is 16.4 and the Price/Book (PB) ratio is 7.71.


Can you provide the financial health for RHO stock?

The financial health rating of ROCHE HOLDING AG-BR (RHO.DE) is 6 / 10.